Leading U.S. medical groups are urging people to get updated flu and COVID-19 vaccinations this fall, working together to provide clear guidance and explain the science behind these recommendations. Flu vaccines are already being distributed, and updated COVID-19 shots have been approved by the Food and Drug Administration (FDA) and are now available nationwide. The winter season also brings the risk of RSV, a respiratory virus that can be especially dangerous for young children and older adults. Many people are unsure about when and who should get these vaccines, leading to confusion. Vaccine recommendations are typically developed by the Centers for Disease Control and Prevention (CDC) and its independent advisory panels. However, last year, some Trump administration health officials began to step back from established guidelines for seasonal viruses and routine childhood vaccines. This advisory panel is still involved in a legal dispute, and the CDC has not provided clear guidance for this fall. To address this gap, major physician organizations, including the American Academy of Pediatrics, American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists, have released tailored guidance for their patient groups. Dr. Sandra Fryhofer of the American Medical Association said that there has been a lot of confusion and inconsistency in vaccine recommendations. To help the public, the AMA is compiling all the latest guidance and research on vaccine safety and effectiveness at SpreadTheFacts.org. According to the guidance, almost everyone aged 6 months and older should get a flu shot, especially those at higher risk, such as people 65 and older, pregnant women, young children, and those with chronic health conditions like asthma or diabetes. The last two flu seasons were particularly severe, with high numbers of child deaths, most of which occurred in unvaccinated children. This season, there are new options for flu vaccines, including one using mRNA technology, similar to the vaccines used for COVID-19. For people aged 50 and older, Moderna’s mFlusiva has shown to be 27% more effective in preventing flu symptoms compared to traditional vaccines. FluMist, a nasal spray vaccine, is also available for people aged 2 to 49 who meet certain health criteria. For the COVID-19 vaccine, higher-risk individuals, including those 65 and older and those with health conditions, are now eligible for FDA approval, but many physicians still recommend it for all adults. Medicare and most private insurers cover these vaccines, and October is considered the best time to get a flu shot, as flu season typically begins in November.